ONC: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30
Net income (loss)	220,431
Depreciation and amortization expense	105,702
Share-based compensation expenses	387,096
Acquired in-process research and development	691
Amortization of research and development cost share liability	-74,844
Impairment of equity investments	34,216
Other items, net	9,595
Accounts receivable	167,294
Inventories	22,662
Other assets	-55,247
Accounts payable	-7,381
Accrued expenses and other payables	165,886
Other liabilities	3,550
Net cash provided by (used in) operating activities	710,233
Purchases of property, plant and equipment	148,317
Purchase of intangible asset	20,000
Proceeds from sale or maturity of investments	1,800
Purchase of in-process research and development	60,691
Other investing activities	10,612
Net cash used in investing activities	-237,820
Proceeds from other debt	885,000
Proceeds from long-term loan	0
Repayment of long-term loan	21,062
Proceeds from short-term loans	221,521
Repayment of short-term loans	275,782
Payments of withholding taxes from share-based awards	24,195
Proceeds from option exercises and employee share purchase plan	177,038
Other financing activities	0
Net cash provided by financing activities	962,520
Effect of foreign exchange rate changes, net	36,862
Net increase (decrease) in cash, cash equivalents, and restricted cash	1,471,795
Cash and cash equivalents at beginning of period	2,638,747
Cash and cash equivalents at end of period	4,110,542

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

ONC: the cashflow